Related Experiment Video
Updated: Jun 22, 2026
05:54
Operation Procedure and Precautions of Thread-Embedding Acupuncture Therapy in Alzheimer
Published on: May 10, 2024
Acupuncture for Alzheimer's disease: a systematic review
1Division of Standard Research, Korea Institute of Oriental Medicine, Daejeon, South Korea. drmslee@gmail.com
International Journal of Clinical Practice
|June 4, 2009
Summary
This review found no evidence that acupuncture effectively treats Alzheimer's disease (AD). Current research does not support acupuncture as a beneficial therapy for improving cognitive function or daily living activities in AD patients.
Area of Science:
- Neurology
- Integrative Medicine
- Clinical Research
Background:
- Acupuncture is a traditional therapy often used for dementia.
- Claims suggest acupuncture can improve intelligence and cognitive function.
- Alzheimer's disease (AD) is a progressive neurodegenerative disorder.
Purpose of the Study:
- To evaluate the clinical evidence for acupuncture's efficacy in treating Alzheimer's disease.
- To synthesize findings from randomized clinical trials (RCTs) on acupuncture for AD.
Main Methods:
- Searched 17 databases from inception to August 2008 for RCTs on needle acupuncture for AD.
- Included studies without language restrictions.
- Assessed methodological quality using the Jadad score.
Main Results:
- Three RCTs met inclusion criteria.
- Two RCTs comparing acupuncture to drug therapy for cognitive function showed no significant difference.
- Meta-analysis indicated drug therapy was superior to acupuncture for activities of daily living.
Conclusions:
- The current evidence base is limited due to a small number of studies.
- Existing research does not support the effectiveness of acupuncture for Alzheimer's disease.
- Further high-quality research is needed to definitively assess acupuncture's role in AD management.
Related Concept Videos
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...